Novacyt S.A. (EPA:ALNOV)
0.3900
+0.0030 (0.78%)
Feb 20, 2026, 5:35 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €27.5 million as of February 20, 2026. Its market cap has decreased by -34.83% in one year.
Market Cap
27.50M
Enterprise Value
12.60M
Revenue
22.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.39
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 27.50M, an increase of 16.75%. That is a compound annual growth rate of 1.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 27.50M | -0.25% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guerbet | 172.89M |
| Carvolix | 151.49M |
| Diagnostic Medical Systems | 33.93M |
| Theraclion | 29.22M |
| Implanet | 27.63M |
| Ikonisys | 25.67M |
| Biosynex | 17.32M |
| Mauna Kea Technologies | 13.28M |